Examining the impact of bone pathology on type I Gaucher disease
- Autores
- Mucci, Juan Marcos; Rozenfeld, Paula Adriana
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Gaucher disease (GD) is an autosomal recessively inherited lysosomal disorder caused by mutations in GBA gene leading to deficient activity of the lysosomal enzyme acid β-glucocerebrosidase. Phenotipically, 3 different forms can be distinguished, being type I Gaucher disease the most frequent one, and characterized by the absence of involvement of the central nervous system. Affected organs are the spleen, liver, bone marrow and bone and, in severe cases, also the lung and kidney. Bone manifestations include bone pain, bone crises, osteopenia, osteoporosis, avascular necrosis and pathological fractures. Nowadays, skeletal alterations are the major cause of morbidity for patients, and a major concern for physicians who treat them, because of variable grade of response and refractoriness of bone pathology to treatment. Pathological mechanisms of bone alterations in GD are still poorly understood. Advances are being achieved in the knowledge of cellular and molecular mechanisms; by means of handle these studies in the field of osteoimmunology. GD as well as other lysosomal disorders is associated to a chronic stimulation of immune system, specially the innate arm. Cellular alteration produces a proinflammatory milieu leading to enhancement of the activity of osteoclasts, the main degradative/resorptive cell of bone. This article focuses on the details of bone alterations, effect of therapies on skeletal pathology, and our current state of knowledge of the complex pathophisiology of this orphan disease
Fil: Mucci, Juan Marcos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
Gaucher Disease
Bone Pathology
Glucocerebrosidase
Osteoimmunology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/31421
Ver los metadatos del registro completo
id |
CONICETDig_60f200dee9f2fc2bb46ee9d4f2476d23 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/31421 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Examining the impact of bone pathology on type I Gaucher diseaseMucci, Juan MarcosRozenfeld, Paula AdrianaGaucher DiseaseBone PathologyGlucocerebrosidaseOsteoimmunologyhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Gaucher disease (GD) is an autosomal recessively inherited lysosomal disorder caused by mutations in GBA gene leading to deficient activity of the lysosomal enzyme acid β-glucocerebrosidase. Phenotipically, 3 different forms can be distinguished, being type I Gaucher disease the most frequent one, and characterized by the absence of involvement of the central nervous system. Affected organs are the spleen, liver, bone marrow and bone and, in severe cases, also the lung and kidney. Bone manifestations include bone pain, bone crises, osteopenia, osteoporosis, avascular necrosis and pathological fractures. Nowadays, skeletal alterations are the major cause of morbidity for patients, and a major concern for physicians who treat them, because of variable grade of response and refractoriness of bone pathology to treatment. Pathological mechanisms of bone alterations in GD are still poorly understood. Advances are being achieved in the knowledge of cellular and molecular mechanisms; by means of handle these studies in the field of osteoimmunology. GD as well as other lysosomal disorders is associated to a chronic stimulation of immune system, specially the innate arm. Cellular alteration produces a proinflammatory milieu leading to enhancement of the activity of osteoclasts, the main degradative/resorptive cell of bone. This article focuses on the details of bone alterations, effect of therapies on skeletal pathology, and our current state of knowledge of the complex pathophisiology of this orphan diseaseFil: Mucci, Juan Marcos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaTaylor & Francis2014info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/31421Mucci, Juan Marcos; Rozenfeld, Paula Adriana; Examining the impact of bone pathology on type I Gaucher disease; Taylor & Francis; Clinical Lipidology; 9; 1; 2014; 61-701758-4299CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/abs/10.2217/clp.13.78info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:13:18Zoai:ri.conicet.gov.ar:11336/31421instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:13:18.911CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Examining the impact of bone pathology on type I Gaucher disease |
title |
Examining the impact of bone pathology on type I Gaucher disease |
spellingShingle |
Examining the impact of bone pathology on type I Gaucher disease Mucci, Juan Marcos Gaucher Disease Bone Pathology Glucocerebrosidase Osteoimmunology |
title_short |
Examining the impact of bone pathology on type I Gaucher disease |
title_full |
Examining the impact of bone pathology on type I Gaucher disease |
title_fullStr |
Examining the impact of bone pathology on type I Gaucher disease |
title_full_unstemmed |
Examining the impact of bone pathology on type I Gaucher disease |
title_sort |
Examining the impact of bone pathology on type I Gaucher disease |
dc.creator.none.fl_str_mv |
Mucci, Juan Marcos Rozenfeld, Paula Adriana |
author |
Mucci, Juan Marcos |
author_facet |
Mucci, Juan Marcos Rozenfeld, Paula Adriana |
author_role |
author |
author2 |
Rozenfeld, Paula Adriana |
author2_role |
author |
dc.subject.none.fl_str_mv |
Gaucher Disease Bone Pathology Glucocerebrosidase Osteoimmunology |
topic |
Gaucher Disease Bone Pathology Glucocerebrosidase Osteoimmunology |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Gaucher disease (GD) is an autosomal recessively inherited lysosomal disorder caused by mutations in GBA gene leading to deficient activity of the lysosomal enzyme acid β-glucocerebrosidase. Phenotipically, 3 different forms can be distinguished, being type I Gaucher disease the most frequent one, and characterized by the absence of involvement of the central nervous system. Affected organs are the spleen, liver, bone marrow and bone and, in severe cases, also the lung and kidney. Bone manifestations include bone pain, bone crises, osteopenia, osteoporosis, avascular necrosis and pathological fractures. Nowadays, skeletal alterations are the major cause of morbidity for patients, and a major concern for physicians who treat them, because of variable grade of response and refractoriness of bone pathology to treatment. Pathological mechanisms of bone alterations in GD are still poorly understood. Advances are being achieved in the knowledge of cellular and molecular mechanisms; by means of handle these studies in the field of osteoimmunology. GD as well as other lysosomal disorders is associated to a chronic stimulation of immune system, specially the innate arm. Cellular alteration produces a proinflammatory milieu leading to enhancement of the activity of osteoclasts, the main degradative/resorptive cell of bone. This article focuses on the details of bone alterations, effect of therapies on skeletal pathology, and our current state of knowledge of the complex pathophisiology of this orphan disease Fil: Mucci, Juan Marcos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Gaucher disease (GD) is an autosomal recessively inherited lysosomal disorder caused by mutations in GBA gene leading to deficient activity of the lysosomal enzyme acid β-glucocerebrosidase. Phenotipically, 3 different forms can be distinguished, being type I Gaucher disease the most frequent one, and characterized by the absence of involvement of the central nervous system. Affected organs are the spleen, liver, bone marrow and bone and, in severe cases, also the lung and kidney. Bone manifestations include bone pain, bone crises, osteopenia, osteoporosis, avascular necrosis and pathological fractures. Nowadays, skeletal alterations are the major cause of morbidity for patients, and a major concern for physicians who treat them, because of variable grade of response and refractoriness of bone pathology to treatment. Pathological mechanisms of bone alterations in GD are still poorly understood. Advances are being achieved in the knowledge of cellular and molecular mechanisms; by means of handle these studies in the field of osteoimmunology. GD as well as other lysosomal disorders is associated to a chronic stimulation of immune system, specially the innate arm. Cellular alteration produces a proinflammatory milieu leading to enhancement of the activity of osteoclasts, the main degradative/resorptive cell of bone. This article focuses on the details of bone alterations, effect of therapies on skeletal pathology, and our current state of knowledge of the complex pathophisiology of this orphan disease |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/31421 Mucci, Juan Marcos; Rozenfeld, Paula Adriana; Examining the impact of bone pathology on type I Gaucher disease; Taylor & Francis; Clinical Lipidology; 9; 1; 2014; 61-70 1758-4299 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/31421 |
identifier_str_mv |
Mucci, Juan Marcos; Rozenfeld, Paula Adriana; Examining the impact of bone pathology on type I Gaucher disease; Taylor & Francis; Clinical Lipidology; 9; 1; 2014; 61-70 1758-4299 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/abs/10.2217/clp.13.78 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Taylor & Francis |
publisher.none.fl_str_mv |
Taylor & Francis |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842980702414438400 |
score |
12.993085 |